Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024 ...Middle East

New preclinical results support the anti-fibrotic potential of engineered macrophages in multiple fibrosis models Engineered TIM4-expressing macrophages correct defective efferocytosis in MASH, demonstrating potent anti-fibrotic activity PHILADELPHIA, Nov. 17, 2024 /PRNewswire/ -- Carisma...

Hence then, the article about carisma therapeutics presents promising new preclinical data on engineered macrophages for the treatment of liver fibrosis at aasld the liver meeting 2024 was published today ( Sunday 17/11/2024 - 03:48 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024 )

Also on site :

• FIFA’s empire of double standards: Why the 2026 World Cup is already a disaster
• This Is Summer 2026’s Hottest Carry-On Trend—and It Completely Eliminates Your Biggest Travel Headache
• Hershey Quietly Debuts a Brand-New Candy Bar Based on a Classic Italian Dessert